Paul Feuerstadt
18PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (18)
Sort by Publication Date:
|Nov 17, 2025
Integrated analysis of the safety of fecal microbiota, live-jslm in adults with recurrent Clostridioides difficile infection from five prospective clinical trials: an update.Christine Lee, Paul Feuerstadt, Thomas Louie
|Nov 13, 2025
Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA®) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial.Sahil Khanna, David Yoho, Daniel Van Handel
|Jun 30, 2025
Assessment of real-world disease severity in patients with eosinophilic esophagitis in the United States.Evan S Dellon, Glenn T Furuta, Paul Feuerstadt
|May 05, 2025
Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA®) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trial.Sahil Khanna, David Yoho, Daniel Van Handel
|Apr 07, 2025
Treatment of Clostridioides difficile : The Times They Are Changing.Paul Feuerstadt, Jessica Allegretti, Sahil Khanna
Pageof 3
Frequent Collaborators
3 joint publications
Sahil Khanna
3 joint publications
Whitfield L Knapple
2 joint publications
Robert Orenstein
1 joint publications
Ziga Vodusek
1 joint publications
Lawrence J Brandt
1 joint publications
Min Yang
1 joint publications
Viviana Garcia-Horton
1 joint publications
Anthony Lembo
1 joint publications
Kyle Staller
1 joint publications
Jessica R Allegretti
